MiR-19a also promotes cell proliferation and migration by targeting the tumor suppressor T-cell intracellular antigen 1 (TIA1) in colorectal cancer [36] and is upregulated in bladder cancer, where it correlates with aggressive tumor phenotypes [37]. The gene discussed is TIA1; the disease is neoplasm.